Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth

Prenatal exposure to high doses of nicotine (greater than 6 mg/kg/day) via maternal infusions has been shown to impair nervous system development and to decrease viability and growth. In the current study, we have examined the effects of infusing pregnant rats with 2 mg/kg of nicotine per day from gestational days 4 through 20. At this lower dose, there was neither interference with maternal weight gain nor any increase in resorption rate. Intrauterine and postnatal growth was maintained at normal or supranormal rates in the exposed offspring. Nevertheless, sufficient nicotine penetrated the fetal brain to cause persistent alterations in [3H]nicotine binding sites, abnormalities of cellular development [assessed by measurements of ornithine decarboxylase (ODC) activity and deoxyribonucleic acid (DNA)], and impairment of development of peripheral noradrenergic projections (assessed by kidney norepinephrine levels); in each case, the neural alterations were virtually equivalent to those obtained previously at the higher, growth-suppressant dosage. These findings indicate that growth impairment alone is insufficient to predict the adverse effects of nicotine on development.

[1]  J. Goldman,et al.  The development of the brain : biological and functional perspectives , 1980 .

[2]  L. C. Murrin,et al.  Nicotine administration to rats: methodological considerations. , 1987, Life sciences.

[3]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[4]  T. Slotkin,et al.  Development of central control of norepinephrine turnover and release in the rat heart: Responses to tyramine, 2-Deoxyglucose and Hydralazine , 1981, Neuroscience.

[5]  T. Slotkin,et al.  Adrenergic control of DNA synthesis in developing rat brain regions: Effects of intracisternal administration of isoproterenol , 1988, Brain Research Bulletin.

[6]  T. Slotkin,et al.  Regulation of rat heart ornithine decarboxylase: change in affinity for ornithine evoked by neuronal, hormonal, and ontogenetic stimuli. , 1979, Molecular pharmacology.

[7]  T. Slotkin,et al.  Development of [3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. , 1987, The Journal of pharmacology and experimental therapeutics.

[8]  M. Rand,et al.  Cigarette Smoking and Plasma Levels of Nicotine , 1972, Nature.

[9]  D. Taylor,et al.  Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. , 1984, Teratology.

[10]  J. Coyle,et al.  Nicotinic acetylcholine binding sites in Alzheimer's disease , 1986, Brain Research.

[11]  H. Goldstein,et al.  Smoking in Pregnancy and Subsequent Child Development , 1973, British medical journal.

[12]  R. D. Schwartz,et al.  In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs , 1985, Journal of neurochemistry.

[13]  A. Nordberg,et al.  Regional [3H]acetylcholine and [3H]nicotine binding in developing mouse brain , 1985, International Journal of Developmental Neuroscience.

[14]  R. D. Schwartz,et al.  Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. , 1983, Science.

[15]  H. Nasrat,et al.  Perinatal effects of nicotine. , 1986, Biology of the neonate.

[16]  T. Slotkin,et al.  Perinatal dietary supplementation with a commercial soy lecithin preparation: effects on behavior and brain biochemistry in the developing rat. , 1985, Developmental psychobiology.

[17]  T. Slotkin,et al.  Role of ornithine decarboxylase and the polyamines in nervous system development: A review , 1986, Brain Research Bulletin.

[18]  J. Faust,et al.  Effects of maternal nicotine injections on brain development in the rat: Ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions , 1986, Brain Research Bulletin.

[19]  T. Slotkin,et al.  Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. , 1988, The Journal of pharmacology and experimental therapeutics.

[20]  R. Zetterström,et al.  Abuse of alcohol, drugs and tobacco during pregnancy--consequences for the child. , 1979, Paediatrician.

[21]  T. Slotkin,et al.  Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. , 1987, The Journal of pharmacology and experimental therapeutics.

[22]  R. Feigin,et al.  Nutrition and the developing nervous system , 1975 .

[23]  R. F. Becker,et al.  The effects of nicotine administration in utero upon activity in the rat , 1970 .

[24]  T. Slotkin,et al.  Perinatal dietary supplementation with a soy lecithin preparation: Effects on development of central catecholaminergic neurotransmitter systems , 1986, Brain Research Bulletin.

[25]  T. Slotkin,et al.  Effects of prenatal nicotine exposure on neuronal development: Selective actions on central and peripheral catecholaminergic pathways , 1987, Brain Research Bulletin.

[26]  J. Tonascia,et al.  The interrelationship of maternal smoking and increased perinatal mortality with other risk factors. Further analysis of the Ontario Perinatal Mortality Study, 1960-1961. , 1974, American journal of epidemiology.

[27]  T. Slotkin,et al.  Perinatal dietary exposure to soy lecithin: Altered sensitivity to central cholinergic stimulation , 1986, International Journal of Developmental Neuroscience.

[28]  M. Winick,et al.  Quantitative changes in DNA, RNA, and protein during prenatal and postnatal growth in the rat. , 1965, Developmental biology.

[29]  A. R. Brooks,et al.  Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development. , 1988, Brain research.

[30]  R. F. Becker,et al.  The effects of maternal nicotine absorption or hypoxic episodes upon appetitive behavior of rat offspring. , 1971, Developmental psychobiology.

[31]  T. Slotkin,et al.  Effects of α-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase, on nucleic acids and proteins in developing rat brain: Critical perinatal periods for regional selectivity , 1986, Neuroscience.

[32]  W. Claycomb.  Biochemical aspects of cardiac muscle differentiation. Possible control of deoxyribonucleic acid synthesis and cell differentiation by adrenergic innervation and cyclic adenosine 3':5'-monophosphate. , 1976, The Journal of biological chemistry.

[33]  A. C. Collins,et al.  Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. , 1983, The Journal of pharmacology and experimental therapeutics.

[34]  T. Slotkin,et al.  Beta adrenergic control of macromolecule synthesis in neonatal rat heart, kidney and lung: relationship to sympathetic neuronal development. , 1987, The Journal of pharmacology and experimental therapeutics.

[35]  M. Brazier.  Growth and development of the brain : nutritional, genetic, and environmental factors , 1975 .

[36]  C. Lau,et al.  Thyroid hormone control of preganglionic innervation of the adrenal medulla and chromaffin cell development in the rat. An ultrastructural, morphometric and biochemical evaluation. , 1988, Brain research. Developmental brain research.

[37]  N. Hagino,et al.  Effect of maternal nicotine on the development of sites for [3H]nicotine binding in the fetal brain , 1985, International Journal of Developmental Neuroscience.

[38]  T. Slotkin,et al.  Regulation of adrenal chromaffin cell development by the central monoaminergic system: Differential control of norepinephrine and epinephrine levels and secretory responses , 1987, Neuroscience.

[39]  T. Slotkin,et al.  Biochemical mechanisms of developmental neurotoxicity of methylmercury. , 1987, Neurotoxicology.

[40]  R. Naeye.  EFFECTS OF MATERNAL CIGARETTE SMOKING ON THE FETUS AND PLACENTA , 1978, British journal of obstetrics and gynaecology.